Vimarsana
Biggest News Aggregation in the World

Page 11 - Negotiation Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Negotiation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Negotiation Program Today - Breaking & Trending Today

An Analysis of the Blizzard of Lawsuits to Block Drug-Price Negotiations - Vimarsana News

An Analysis of the Blizzard of Lawsuits to Block Drug-Price Negotiations

Industry is using the same old playbook

Legal Battles Continue Over Inflation Reduction Act's Drug Price Negotiation Measures - Life Sciences, Biotechnology & Nanotechnology - Vimarsana News

Legal Battles Continue Over Inflation Reduction Act's Drug Price Negotiation Measures - Life Sciences, Biotechnology & Nanotechnology

In recent months, six different lawsuits have been filed challenging the Inflation Reduction Act (IRA)'s Drug Price Negotiation Program (the "Program"), with a flurry of activity likely in the coming months...

Source: mondaq.com
From Private Equity Ownership To PBMs And Drug Pricing: Congress Scrutinizes The Health Care Industry - Healthcare - Vimarsana News

From Private Equity Ownership To PBMs And Drug Pricing: Congress Scrutinizes The Health Care Industry - Healthcare

The first six months of the 118th Congress have been an active stretch for the House and Senate committees with jurisdiction over health care issues. Legislative activity has spanned the health...

Source: mondaq.com
CMS Proceeds Full Steam Ahead with Medicare Drug Price Negotiation Program | Wilson Sonsini Goodrich & Rosati - Vimarsana News

CMS Proceeds Full Steam Ahead with Medicare Drug Price Negotiation Program | Wilson Sonsini Goodrich & Rosati

Almost 11 months after President Biden signed the Medicare Drug Price Negotiation Program (“Negotiation Program”) into law, the Centers for Medicare and Medicaid Services (CMS) has...

From Private Equity Ownership to PBMs and Drug Pricing: Congress Scrutinizes the Health Care Industry | Akin Gump Strauss Hauer & Feld LLP - Vimarsana News

From Private Equity Ownership to PBMs and Drug Pricing: Congress Scrutinizes the Health Care Industry | Akin Gump Strauss Hauer & Feld LLP

Congress is taking a closer look at business practices in the health care sector and considering bipartisan reforms in light of increasing consolidation and its perceived affects on...